La cadena de opciones muestra datos clave de las opciones de acciones de Imunon a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Imunon..

Imunon (NASDAQ:IMNN) Bolsa, Cadena de Opciones

IMUNON INC

Imunon

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Box,Headquarters,In,Redwood,City,,California,,Usa,-,June,8,

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BROG

CETX

CODI

GLXY

IFRX

IMNN

JFBR

JOBY

LAES

LVWR

NEHC

OKTA

PMAX

SGBX

SONN

WORX

Descubre qué acciones destacan en el premercado de EE. UU., desde subidas explosivas como Box hasta caídas por anuncios clave.

Las acciones de Box se disparan un 12%; Aquí están 20 acciones que se mueven en el premercado

New,York,,Usa,-,January,07,,2025:,E2open,Website,Displayed

ABEO

BLMZ

CMBM

DGLY

DGNX

ETWO

GORV

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IXHL

ONCY

PRTA

SBET

SILO

VVPR

Consulta las acciones con mayores subidas y caídas en el premercado estadounidense de hoy, incluyendo tecnológicas, biotecnológicas y más.

Las acciones de E2open se disparan un 25%; aquí están 20 acciones que se mueven en el premercado

HOVR

HOVRW

New Horizon Aircraft And ZeroAvia Plan To Work Together On Developing Regional Hydrogen-Electric VTOL Air Travel

OFAL

OFA Group Enters Committed Equity Purchase Agreement With Atsion Opportunity Fund LLC – Series 1 For Up To $100M, With Option To Expand To $200M Upon Mutual Agreement

<h3>Gainers</h3>
<ul>
<li>INNEOVA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INEO#NASDAQ">INEO</a>) shares moved upwards by 10.2% to $1.3 during Tuesday's pre-market session. The company's market cap stands at $11.6 million. </li>
<li>Jianzhi Education Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) stock rose 9.93% to $1.77. The market value of their outstanding shares is at $1.2 million. </li>
<li>Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) shares moved upwards by 9.58% to $6.17. The market value of their outstanding shares is at $99.8 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock increased by 9.21% to $5.45. The market value of their outstanding shares is at $20.0 million. </li>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSA#NASDAQ">VSA</a>) shares rose 7.69% to $1.54. The company's market cap stands at $14.2 million. </li>
<li>Aureus Greenway Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGH#NASDAQ">AGH</a>) stock increased by 7.43% to $0.65. The company's market cap stands at $8.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kaival Brands Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) stock fell 20.4% to $0.54 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.8 million. </li>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) stock fell 10.66% to $0.55. The market value of their outstanding shares is at $5.2 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) shares fell 10.0% to $1.71. The company's market cap stands at $64.1 million. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock fell 7.81% to $0.65. The company's market cap stands at $14.1 million. </li>
<li>Autozi Internet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) stock declined by 6.4% to $0.25. The company's market cap stands at $30.4 million. </li>
<li>Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) stock decreased by 5.05% to $20.33. The market value of their outstanding shares is at $1.5 billion. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FTEL

INEO

KAVL

LOBO

RENT

RRGB

RVLV

RYET

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) stock rose 127.6% to $6.02 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.6 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock moved upwards by 44.46% to $4.78. The market value of their outstanding shares is at $5.2 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) stock rose 40.11% to $0.96. The market value of their outstanding shares is at $11.5 million. </li>
<li>OKYO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKYO#NASDAQ">OKYO</a>) stock increased by 20.15% to $3.1. The market value of their outstanding shares is at $96.5 million. </li>
<li>Cadrenal Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>) shares rose 19.43% to $14.93. The market value of their outstanding shares is at $24.5 million. </li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) shares rose 16.85% to $2.53. The company's market cap stands at $3.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Organogenesis Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>) stock declined by 24.3% to $3.4 during Tuesday's pre-market session. The company's market cap stands at $569.5 million. </li>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) shares declined by 18.05% to $7.9. The company's market cap stands at $30.5 million. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) stock decreased by 17.53% to $0.58. The market value of their outstanding shares is at $27.4 million. </li>
<li>Burning Rock Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNR#NASDAQ">BNR</a>) stock decreased by 17.5% to $3.82. The company's market cap stands at $47.4 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) shares decreased by 15.6% to $0.4. The market value of their outstanding shares is at $9.7 million. </li>
<li>MiNK Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INKT#NASDAQ">INKT</a>) shares fell 13.82% to $35.0. The market value of their outstanding shares is at $161.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CVKD

CYCC

INKT

KAPA

OKYO

ORGO

RANI

SXTP

TLPH

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Li Bang International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBGJ#NASDAQ">LBGJ</a>) stock increased by 9.7% to $1.55 during Tuesday's pre-market session. The company's market cap stands at $26.4 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares increased by 8.81% to $0.08. The market value of their outstanding shares is at $10.3 million. </li>
<li>TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) shares increased by 8.19% to $0.84. The company's market cap stands at $37.8 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) stock moved upwards by 6.95% to $3.03. The market value of their outstanding shares is at $98.8 million. </li>
<li>Custom Truck One Source (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTOS#NYSE">CTOS</a>) shares rose 6.79% to $5.5. The market value of their outstanding shares is at $1.1 billion. </li>
<li>Virco Mfg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRC#NASDAQ">VIRC</a>) stock increased by 6.74% to $8.7. The market value of their outstanding shares is at $128.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>OFA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFAL#NASDAQ">OFAL</a>) shares decreased by 23.2% to $2.55 during Tuesday's pre-market session. The company's market cap stands at $46.2 million. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) stock declined by 18.62% to $1.53. The market value of their outstanding shares is at $14.1 million. </li>
<li>Stardust Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) shares decreased by 14.38% to $0.41. The company's market cap stands at $39.0 million. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) stock declined by 7.44% to $0.38. The company's market cap stands at $13.1 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) stock decreased by 7.01% to $0.95. The company's market cap stands at $4.2 million. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) stock fell 6.35% to $0.4. The company's market cap stands at $14.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

CTOS

LBGJ

MCRP

SDST

SGLY

TPIC

VIRC

WATT

12 Industrials Stocks Moving In Tuesday's Pre-Market Session

JMP Securities analyst Jordan Bender maintains Sportradar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) with a Market Outperform and raises the price target from $25 to $30.

Price Target

Analyst Ratings

SRAD

JMP Securities Maintains Market Outperform on Sportradar Gr, Raises Price Target to $30

<h3>Gainers</h3>
<ul>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) stock moved upwards by 62.5% to $2.73 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.4 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock increased by 18.19% to $0.65. The market value of their outstanding shares is at $3.8 million. </li>
<li>Kingsoft Cloud Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) shares increased by 17.07% to $14.88. The company's market cap stands at $3.4 billion. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares moved upwards by 16.13% to $1.23. The company's market cap stands at $27.3 million. </li>
<li>VNET Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>) shares increased by 14.89% to $9.1. The company's market cap stands at $2.1 billion. </li>
<li>GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) stock increased by 13.42% to $39.7. The market value of their outstanding shares is at $6.7 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TROOPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) shares declined by 30.6% to $0.93 during Tuesday's pre-market session. The company's market cap stands at $136.1 million. </li>
<li>Argo Blockchain plc - 8.75% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBKL#NASDAQ">ARBKL</a>) stock declined by 13.64% to $3.8. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock fell 8.99% to $3.95. The company's market cap stands at $6.5 million. </li>
<li>Datavault AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVLT#NASDAQ">DVLT</a>) shares decreased by 8.45% to $0.63. The market value of their outstanding shares is at $45.3 million. </li>
<li>Sequans Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) stock declined by 7.61% to $4.98. The market value of their outstanding shares is at $769.2 million. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) shares declined by 7.5% to $5.0. The company's market cap stands at $12.8 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

Argo Blockchain plc - 8.75% Senior Notes due 2026

ARBKL

DVLT

MOVE

SOBR

SQNS

TROO

VNET

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

B of A Securities analyst Justin Post maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and raises the price target from $765 to $775.

B of A Securities Maintains Buy on Meta Platforms, Raises Price Target to $775

ZenaTech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) (FSE: 49Q) (BMV:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#BMV">ZENA</a>) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces it will accelerate expansion of its Phoenix Arizona-based facilities -- including tripling the square footage size -- to enable full US drone manufacturing, assembly and testing. This expansion comes earlier than expected due to the recent transformative US policy directives from the White House, the Department of Defense, and the recently passed ‘One Big Beautiful Bill' that collectively have unlocked federal funding for domestic production, cut outdated certification and procurement barriers, and fast-tracked deployment directly to frontline units without requiring Blue or Green UAS (Unmanned Aerial System) certification.
These new directives make it dramatically easier and faster for American drone companies—especially those building Group 1 and 2 affordable drone systems—to sell directly to the military, scale production, and innovate without delays from traditional defense procurement bottlenecks. Together, they signal a clear national priority: build drones in America, field them fast, and outpace adversaries.

BMV:ZENA

ZENA

ZenaTech To Accelerate Expansion Of Phoenix Arizona-Based Facilities To Enable Full US Drone Manufacturing, Assembly And Testing

BIDU

UBER

Baidu And Uber Announce Partnership To Deploy Thousands Of Baidu's Apollo Go On Uber Platform Across Markets Outside US And Mainland China

JMP Securities analyst Aaron Hecht initiates coverage on Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) with a Market Outperform rating and announces Price Target of $30.

Initiation

JMP Securities Initiates Coverage On Forestar Group with Market Outperform Rating, Announces Price Target of $30

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer discretionary sector.
<h3 class="wp-block-heading">Dine Brands Global, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIN#NYSE">DIN</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 8.43%</li>
<li>Barclays analyst Jeff Kessler maintained an Equal-Weight rating and raised the price target from $21 to $24 on May 8, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Truist Securities analyst Jake Bartlett maintained a Hold rating and slashed the price target from $27 to $23 on May 8, 2025. This analyst has an accuracy rate of 74%.</li>
<li>Recent News: On June 5, Dine Brands Global priced its $600 million securitized financing facility.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">DIN news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="915" height="828" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080241/image-172.png" alt="" class="wp-image-985807" style="width:643px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080241/image-172.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080241/image-172-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080241/image-172-768x695.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure>
<h3 class="wp-block-heading">Jack in the Box Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 8.29%</li>
<li>Stifel analyst Chris O'Cull downgraded the stock from Buy to Hold and cut the price target from $32 to $20 on June 20, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Truist Securities analyst Jake Bartlett downgraded the stock from Buy to Hold and lowered the price target from $51 to $22 on May 27, 2025. This analyst has an accuracy rate of 74%.</li>
<li>Recent News: The company will release third-quarter earnings release after the closing bell on Wednesday, Aug. 6.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">JACK news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="915" height="457" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080316/image-173.png" alt="" class="wp-image-985813" style="width:619px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080316/image-173.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080316/image-173-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080316/image-173-768x384.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure>
<h3 class="wp-block-heading">Monro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNRO#NASDAQ">MNRO</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 7.13%</li>
<li>Wells Fargo analyst David Lantz maintained an Equal-Weight rating and raised the price target from $15 to $16 on May 29, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wedbush analyst Seth Basham maintained an Outperform rating and cut the price target from $27 to $19 on April 1, 2025. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On May 28, Monro reported a fourth-quarter revenue beat and approved a first-quarter cash dividend of 28 cents per share.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest MNRO <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="911" height="852" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080344/image-174.png" alt="" class="wp-image-985815" style="width:618px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080344/image-174.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080344/image-174-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15080344/image-174-768x718.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More:
<ul class="wp-block-list">
<li> J<a href="https://www.benzinga.com/markets/equities/25/07/46408189/jpmorgan-wells-fargo-and-3-stocks-to-watch-heading-into-tuesday">PMorgan, Wells Fargo And 3 Stocks To Watch Heading Into Tuesday</a></li>
</ul>
Photo via Shutterstock

Long Ideas

Dividends

JACK

MNRO

Wall Street's Most Accurate Analysts Spotlight On 3 Consumer Stocks Delivering High-Dividend Yields

Largest cardiac surgery device trial ever with 6,500 patients enrolled, this landmark trial evaluates the stroke reduction benefit with AtriClip devices for the over one million cardiac surgery patients globally without a preoperative Afib diagnosis
AtriCure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRC#NASDAQ">ATRC</a>), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced the completion of enrollment in the left atrial appendage exclusion for prophylactic stroke reduction (LeAAPS) clinical trial (NCT05478304). Initiated in January 2023, LeAAPS enrolled 6,500 patients across 137 centers globally.
LeAAPS is a prospective, randomized, blinded, superiority, investigational device exemption (IDE) trial evaluating the AtriClip&#xAE; LAA Exclusion System for the prevention of ischemic stroke and systemic arterial embolism in cardiac surgery patients without a history of Afib—a large and often underserved population at elevated risk for these events. It is estimated that well over one million cardiac surgery procedures occur annually and more than 70% of these patients have no history of Afib before surgery.
AtriCure first entered the LAA management market with FDA 510(k) clearance of the AtriClip System in 2010. Today, AtriClip devices are the most widely used LAA management device worldwide. The company plans to use LeAAPS data to support an expanded indication for stroke prevention in patients at elevated risk of ischemic stroke.

ATRC

AtriCure Completes Enrollment In Left Atrial Appendage Exclusion For Prophylactic Stroke Reduction Clinical Trial

Biotech

General

AEMD

Aethlon Medical Announces Independent Data Safety Monitoring Board Overseeing AEMD-2022-06 Trial Recommended Advancing Without Modification

AAPL

Apple Announces $500M Commitment With MP Materials; Co. Commits To Buying American-Made Rare Earth Magnets Developed At MP Materials' Fort Worth Facility

Jianzhi Education Regains Nasdaq Compliance

Guidance

NEGG

Newegg Commerce Now Expects Six Months Ended June 30, 2025 Net Sales Of $678.3M - $713.1M, Net Loss Of $1.7M - $5.7M, And GMV Between $827.7M And $870.1M

Asset Sales

Wag! Group Sells Furscription To MWI Veterinary Supply; Amount Not Disclosed

Redburn Atlantic analyst Agnieszka Pustula upgrades Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) from Sell to Neutral and announces $30 price target.

Upgrades

Redburn Atlantic Upgrades Warner Music Gr to Neutral, Announces $30 Price Target

Kairos Pharma Announces Safety Results From Phase 2 Trial Of ENV-105 In Advanced Prostate Cancer; Analysis Demonstrated ENV-105 Was Well Tolerated When Combined With Standard Of Care Hormone Therapy

Press Releases

IMUNON CEO RECAPS A YEAR OF CLINICAL ACHIEVEMENT AND SOLID FUNDAMENTALS

IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study

IMUNON to Present at the Zacks SCR Life Sciences Virtual Investor Forum on June 12th

Life Sciences Investor Forum Agenda Announced for June 11th-12th

Small-Cap Disruptors KZIA, SNYR, HSDT, TRNR, PRSO Lead Momentum – More Microcap Stocks Inside

Life Sciences Investor Forum: Now Available for Online Viewing

IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™

IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

IMUNON Submits Plan in Consultation with the Exchange to Ensure Compliance with Nasdaq's Listing Requirement, Anticipates Additional Compliance Period

IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan

Comments

Imunon

Imunon (IMNN) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL